VanEck Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $216M | Sell |
1,792,705
-2,071,624
| -54% | -$239M | 0.16% | 113 |
|
|
2025
Q4 | $407M | Sell |
3,864,329
-1,460,704
| -27% | -$137M | 0.34% | 56 |
|
|
2025
Q3 | $447M | Buy |
5,325,033
+2,029,342
| +62% | +$167M | 0.42% | 51 |
|
|
2025
Q2 | $261M | Buy |
3,295,691
+203,845
| +7% | +$16.2M | 0.3% | 77 |
|
|
2025
Q1 | $278M | Sell |
3,091,846
-57,995
| -2% | -$5.41M | 0.36% | 72 |
|
|
2024
Q4 | $313M | Buy |
3,149,841
+2,778,388
| +748% | +$286M | 0.4% | 60 |
|
|
2024
Q3 | $39.5M | Buy |
371,453
+49,891
| +16% | +$5.93M | 0.05% | 198 |
|
|
2024
Q2 | $39.8M | Buy |
321,562
+13,148
| +4% | +$1.69M | 0.06% | 188 |
|
|
2024
Q1 | $40.7M | Buy |
308,414
+75,291
| +32% | +$9.28M | 0.06% | 181 |
|
|
2023
Q4 | $25.4M | Sell |
233,123
-406,270
| -64% | -$42.2M | 0.05% | 208 |
|
|
2023
Q3 | $65.8M | Buy |
639,393
+34,220
| +6% | +$3.69M | 0.14% | 131 |
|
|
2023
Q2 | $69.8M | Buy |
605,173
+17,821
| +3% | +$2.02M | 0.15% | 130 |
|
|
2023
Q1 | $62.5M | Sell |
587,352
-138,519
| -19% | -$15M | 0.14% | 132 |
|
|
2022
Q4 | $80.5M | Sell |
725,871
-122,403
| -14% | -$12.5M | 0.21% | 119 |
|
|
2022
Q3 | $73.1M | Sell |
848,274
-1,177,605
| -58% | -$105M | 0.22% | 116 |
|
|
2022
Q2 | $185M | Sell |
2,025,879
-995,014
| -33% | -$88.2M | 0.49% | 48 |
|
|
2022
Q1 | $248M | Sell |
3,020,893
-107,916
| -3% | -$8.51M | 0.51% | 43 |
|
|
2021
Q4 | $240M | Buy |
3,128,809
+161,776
| +5% | +$12.9M | 0.55% | 44 |
|
|
2021
Q3 | $223M | Buy |
2,967,033
+343,962
| +13% | +$26.2M | 0.56% | 39 |
|
|
2021
Q2 | $204M | Buy |
2,623,071
+408,110
| +18% | +$30.4M | 0.48% | 45 |
|
|
2021
Q1 | $163M | Buy |
2,214,961
+482,194
| +28% | +$35.6M | 0.44% | 49 |
|
|
2020
Q4 | $135M | Buy |
1,732,767
+179,166
| +12% | +$13.7M | 0.39% | 51 |
|
|
2020
Q3 | $123M | Buy |
1,553,601
+56,553
| +4% | +$4.43M | 0.39% | 47 |
|
|
2020
Q2 | $110M | Buy |
1,497,048
+201,575
| +16% | +$15.2M | 0.38% | 42 |
|
|
2020
Q1 | $95.1M | Sell |
1,295,473
-32,705
| -2% | -$2.57M | 0.48% | 36 |
|
|
2019
Q4 | $115M | Buy |
1,328,178
+734,720
| +124% | +$60.3M | 0.45% | 37 |
|
|
2019
Q3 | $47.7M | Buy |
593,458
+419,779
| +242% | +$33.6M | 0.22% | 97 |
|
|
2019
Q2 | $13.9M | Sell |
173,679
-7,259
| -4% | -$556K | 0.07% | 196 |
|
|
2019
Q1 | $14.4M | Sell |
180,938
-81,168
| -31% | -$6.07M | 0.07% | 192 |
|
|
2018
Q4 | $19.1M | Sell |
262,106
-349,737
| -57% | -$24.7M | 0.1% | 168 |
|
|
2018
Q3 | $41.4M | Sell |
611,843
-357,050
| -37% | -$22.7M | 0.2% | 118 |
|
|
2018
Q2 | $56.1M | Buy |
968,893
+55,197
| +6% | +$3.11M | 0.26% | 88 |
|
|
2018
Q1 | $47.5M | Buy |
913,696
+73,038
| +9% | +$3.94M | 0.24% | 94 |
|
|
2017
Q4 | $45.1M | Buy |
840,658
+350,908
| +72% | +$19.5M | 0.22% | 103 |
|
|
2017
Q3 | $29.9M | Buy |
489,750
+265,373
| +118% | +$16.1M | 0.15% | 146 |
|
|
2017
Q2 | $13.7M | Sell |
224,377
-40,624
| -15% | -$2.47M | 0.08% | 202 |
|
|
2017
Q1 | $16.1M | Buy |
265,001
+30,865
| +13% | +$1.87M | 0.07% | 183 |
|
|
2016
Q4 | $13.2M | Buy |
234,136
+34,700
| +17% | +$2.03M | 0.07% | 184 |
|
|
2016
Q3 | $11.9M | Sell |
199,436
-40,755
| -17% | -$2.38M | 0.06% | 187 |
|
|
2016
Q2 | $13.2M | Sell |
240,191
-19,155
| -7% | -$1.02M | 0.07% | 176 |
|
|
2016
Q1 | $13.1M | Sell |
259,346
-100,382
| -28% | -$4.92M | 0.09% | 148 |
|
|
2015
Q4 | $18.1M | Sell |
359,728
-739,191
| -67% | -$37.3M | 0.14% | 144 |
|
|
2015
Q3 | $51.8M | Sell |
1,098,919
-2,826
| -0.3% | -$150K | 0.4% | 64 |
|
|
2015
Q2 | $59.9M | Sell |
1,101,745
-40,995
| -4% | -$2.3M | 0.35% | 76 |
|
|
2015
Q1 | $62.7M | Buy |
1,142,740
+856,829
| +300% | +$48.5M | 0.36% | 75 |
|
|
2014
Q4 | $15.5M | Sell |
285,911
-129,081
| -31% | -$7.19M | 0.1% | 163 |
|
|
2014
Q3 | $23.5M | Buy |
414,992
+58,150
| +16% | +$3.27M | 0.12% | 133 |
|
|
2014
Q2 | $19.7M | Buy |
356,842
+53,477
| +18% | +$2.92M | 0.09% | 146 |
|
|
2014
Q1 | $16.4M | Buy |
303,365
+17,721
| +6% | +$918K | 0.08% | 151 |
|
|
2013
Q4 | $13.6M | Buy |
285,644
+5,914
| +2% | +$270K | 0.07% | 159 |
|
|
2013
Q3 | $12.7M | Sell |
279,730
-63,671
| -19% | -$2.91M | 0.06% | 155 |
|
|
2013
Q2 | $15.2M | Buy |
+343,401
| New | +$15.3M | 0.08% | 119 |
|
Other funds holding MRK
VCM
VPM
VanEck Associates's MRK Position: Q1 2026 in Review
VanEck Associates reduced its Merck (MRK) stake by 54% in Q1 2026, selling an estimated $239M and leaving 1,792,705 shares worth $216M. The position accounts for 0.16% of the portfolio, ranked #113.
VanEck Associates first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $447M in Q3 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- VanEck Associates held 1,792,705 shares of Merck worth $216M as of Q1 2026.
- VanEck Associates sold 2,071,624 Merck shares in Q1 2026, an estimated $239M.
- Merck made up 0.16% of VanEck Associates's portfolio in Q1 2026, its #113 holding.
- VanEck Associates first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- VanEck Associates's Merck position peaked at $447M in Q3 2025.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.